Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
besifloxacin (besivance) (1 trial)
gatifloxacin (Zymar) (1 trial)
moxifloxacin (avelox) (1 trial)
Communicable Diseases (Phase 2)
Corneal Ulcer (Phase 2)
Infections (Phase 2)
Ulcer (Phase 2)
Trials (1 total)
Trial APIs (3 total)